Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Alex Gural"'
Autor:
Max Topp, Monika Dlugosz-Danecka, Aleksander B. Skotnicki, Galina Salogub, Andreas Viardot, Andreas K. Klein, Georg Hess, Christian S. Michel, Sebastian Grosicki, Alex Gural, Sylvia E. Schwarz, Kerstin Pietzko, Ulrike Gärtner, András Strassz, Leila Alland, Jiri Mayer
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-11 (2023)
Abstract Background The prognosis for patients with relapsed and/or refractory (R/R) non-Hodgkin’s lymphoma (NHL) or acute lymphoblastic leukaemia (ALL) remains poor, with existing treatments having significant side effects. Developed for the treat
Externí odkaz:
https://doaj.org/article/733ebcc0ead14adca31fae5c33809819
Autor:
Max Topp, Monika Dlugosz-Danecka, Aleksander B. Skotnicki, Galina Salogub, Andreas Viardot, Andreas K. Klein, Georg Hess, Christian S. Michel, Sebastian Grosicki, Alex Gural, Sylvia E. Schwarz, Kerstin Pietzko, Ulrike Gärtner, András Strassz, Leila Alland, Jiri Mayer
Background The prognosis for patients with relapsed and/or refractory (R/R) non-Hodgkin’s lymphoma (NHL) or acute lymphoblastic leukaemia (ALL) remains poor, with existing treatments having significant side effects. Developed for the treatment of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c0e89131dea4b976b7f85b86b2d5471
https://doi.org/10.21203/rs.3.rs-1113841/v1
https://doi.org/10.21203/rs.3.rs-1113841/v1
Autor:
David Lavie, Diana Libster, Alex Gural, Moshe E. Gatt, Noam Benyamini, Yossef Barshay, Chezi Ganzel, Adir Shaulov, Batia Avni, Neta Goldschmidt
Publikováno v:
American Journal of Hematology. 92:131-135
Multiple myeloma (MM) and primary systemic light chain amyloidosis (AL) are both chronic plasma cell dyscrasias with different clinical expression but limited treatment options for relapsed refractory disease. We report the effect of the addition of
Autor:
Marina Orevi, Alex Gural, David Lavie, Geffen Kleinstern, Neta Goldschmidt, Moshe E. Gatt, Diana Libster, Ora Paltiel, Dina Ben-Yehuda
Publikováno v:
Cancer Chemotherapy and Pharmacology. 77:1053-1060
Outcomes in primary mediastinal B cell lymphoma (PMBL) improved with the introduction of dose intense treatments, consolidation radiotherapy and rituximab. DA-EPOCH-R, which omits radiotherapy has been adopted with worldwide enthusiasm, despite lack
Autor:
Adir, Shaulov, Chezi, Ganzel, Noam, Benyamini, Yossef, Barshay, Neta, Goldschmidt, David, Lavie, Diana, Libster, Alex, Gural, Batia, Avni, Moshe E, Gatt
Publikováno v:
American journal of hematology. 92(2)
Multiple myeloma (MM) and primary systemic light chain amyloidosis (AL) are both chronic plasma cell dyscrasias with different clinical expression but limited treatment options for relapsed refractory disease. We report the effect of the addition of
Autor:
Riki Perlman, Julia Abramowitz, Yoav Smith, Rania Samman, Alex Gural, Dina Ben-Yehuda, Tzahi Neuman
Publikováno v:
Blood. 116:5111-5111
Abstract 5111 The pathway controlled by the p53 tumor-suppressor protein is altered in most, if not all, human cancers and the TP53 gene itself is mutated in half of all human tumors. However, mutations in the TP53 gene are rare in human hematologica